secwatch.observer — SEC 8-K summary
======================================

Issuer:     Matinas BioPharma Holdings, Inc. (MTNB)
CIK:        0001582554
Form:       8-K
Filed at:   2024-08-20T23:59:59+00:00
Accession:  0001493152-24-033263
Event type: other_material
Sentiment:  neutral
Materiality: 0.65
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Matinas BioPharma announces 1-for-50 reverse stock split effective Aug 30, 2024
-------------------------------------------------------------------------------

- Board approved 1-for-50 reverse stock split and reduction of authorized shares from 500M to 250M.
- Effective at 5:00 PM EST on Aug 30, 2024; split-adjusted trading under symbol MTNB begins Sep 3.
- Fractional shares rounded up to nearest whole share; no cash paid for fractions.
- Company believes split will help maintain NYSE American listing; may pursue Nasdaq uplisting later.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1582554/000149315224033263/0001493152-24-033263-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1582554/000149315224033263/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-033263

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer